Research progress of new antioxidants in urological neoplasms

doi:10.3760/cma.j.issn.1673-422X.2019.01.012

Abstract

Abstract: Antioxidants are important substances in the body against oxidative stress, which can maintain the balance of redox substances by reducing the content of reactive oxygen species in cells. Studies have shown that new antioxidants have significant inhibitory effects on the growth of urological neoplasms by inhibiting tumor cell proliferation, inducing apoptosis, disturbing angiogenesis and metastasis of tumor cells. Antioxidants are of great value in the prevention and treatment of urinary system tumors and are expected to become new antitumor drugs.

Key words: Antioxidants, Reactive oxygen species, Urologic neoplasms

Song Jiarui, Zhang Bin, Yang Zhongwen, Xu Baocai, Wang Chao, Ma Ming. Research progress of new antioxidants in urological neoplasms[J]. Journal of International Oncology, 2019, 46(1): 54-56.

References

［1］ Ha US, Bae WJ, Kim SJ, et al. Anthocyanin induces apoptosis of DU145 cells in vitro and inhibits xenograft growth of prostate cancer［J］. Yonsei Med J, 2015, 56(1): 16-23. DOI: 10.3349/ymj.2015.56.1.16. ［2］ Ko H, Jeong MH, Jeon H, et al. Delphinidin sensitizes prostate cancer cells to TRAILinduced apoptosis, by inducing DR5 and causing caspasemediated HDAC3 cleavage［J］. Oncotarget, 2015, 6(12): 9970-9984. DOI: 10.18632/oncotarget.3667. ［3］ Jeong MH, Ko H, Jeon H, et al. Delphinidin induces apoptosis via cleaved HDAC3mediated p53 acetylation and oligomerization in prostate cancer cells［J］. Oncotarget, 2016, 7(35): 56767-56780. DOI: 10.18632/oncotarget.10790. ［4］ Dhar S, Kumar A, Rimando AM, et al. Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer［J］. Oncotarget, 2015, 6(29): 27214-27226. DOI: 10.18632/oncotarget.4877. ［5］ Chen YA, Lien HM, Kao MC, et al. Sensitization of radioresistant prostate cancer cells by resveratrol isolated from arachis hypogaea stems［J］. PLoS One, 2017, 12(1): e0169204. DOI: 10.1371/journal.pone.0169204. ［6］ Singh SK, Banerjee S, Acosta EP, et al. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway［J］. Oncotarget, 2017, 8(10): 17216-17228. DOI: 10.18632/oncotarget.15303. ［7］ Vanella L, Di Giacomo C, Acquaviva R, et al. Apoptotic markers in a prostate cancer cell line: effect of ellagic acid［J］. Oncol Rep, 2013, 30(6): 2804-2810. DOI: 10.3892/or.2013.2757. ［8］ NaikiIto A, Chewonarin T, Tang M, et al. Ellagic acid, a component of pomegranate fruit juice, suppresses androgendependent prostate carcinogenesis via induction of apoptosis［J］. Prostate, 2015, 75(2): 151-160. DOI: 10.1002/pros.22900. ［9］ Eskandari E, Heidarian E, Amini SA, et al. Evaluating the effects of ellagic acid on pSTAT3, pAKT, and pERK1/2 signaling pathways in prostate cancer PC3 cells［J］. J Cancer Res Ther, 2016, 12(4): 1266-1271. DOI: 10.4103/0973-1482.165873. ［10］ Ni X, Yu H, Wang S, et al. Astaxanthin inhibits PC3 xenograft prostate tumor growth in nude mice［J］. Mar Drugs, 2017, 15(3). pii: E66. DOI: 10.3390/md15030066. ［11］ Higgins JA, Zainol M, Brown K, et al. Anthocyans as tertiary chemopreventive agents in bladder cancer: antioxidant mechanisms and interaction with mitomycin C［J］. Mutagenesis, 2014, 29(4): 227235. DOI: 10.1093/mutage/geu009. ［12］ Li WL, Yu HY, Zhang XJ, et al. Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer［J］. Oncol Rep, 2018, 40(1): 73-82. DOI: 10.3892/or.2018.6421. ［13］ Zhou C, Ding J, Wu Y. Resveratrol induces apoptosis of bladder cancer cells via miR 21 regulation of the Akt/Bcl 2 signaling pathway［J］. Mol Med Rep, 2014, 9(4): 1467-1473. DOI: 10.3892/mmr.2014.1950. ［14］ Alayev A, Salamon RS, Schwartz NS, et al. Combination of rapamycin and resveratrol for treatment of bladder cancer［J］. J Cell Physiol, 2017, 232(2): 436-446. DOI: 10.1002/jcp.25443. ［15］ Bai Y, Yang H, Zhang G, et al. Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells［J］. Mol Med Rep, 2017, 15(2): 885-889. DOI: 10.3892/mmr.2016.6051. ［16］ Qiu Z, Zhou B, Jin L, et al. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells［J］. Food Chem Toxicol, 2013, 59(6): 428-437. DOI: 10.1016/j.fct.2013.06.025. ［17］ Ho CC, Huang AC, Yu CS, et al. Ellagic acid induces apoptosis in TSGH8301 human bladder cancer cells through the endoplasmic reticulum stressand mitochondriadependent signaling pathways［J］. Environ Toxicol, 2015, 29(11): 1262-1274. DOI: 10.1002/tox.21857. ［18］ Ceci C, Tentori L, Atzori MG, et al. Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth［J］. Nutrients, 2016, 8(11). pii: E744. DOI: 10.3390/nu8110744. ［19］ Liu X, Zhang D, Hao Y, et al. Cyanidin curtails renal cell carcinoma tumorigenesis［J］. Cell Physiol Biochem, 2018, 46(6): 2517-2531. DOI: 10.1159/000489658. ［20］ Kim C, Baek SH, Um JY, et al. Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP2 tyrosine phosphatases and potentiates sorafenibinduced apoptosis in renal cell carcinoma［J］. BMC Nephrol, 2016, 17: 19. DOI: 10.1186/s1288201602337. ［21］ Liu Q, Fang Q, Ji S, et al. Resveratrolmediated apoptosis in renal cell carcinoma via the p53/AMP activated protein kinase/mammalian target of rapamycin autophagy signaling pathway［J］. Mol Med Rep, 2018, 17(1): 502-508. DOI: 10.3892/mmr.2017.7868.

[1]	Wang Zihao, Wang Yu, Yang Xin, He Yi, Mo Xingkui, Yuan Tao. Research progress on the molecular mechanism and related treatments of ferroptosis in osteosarcoma [J]. Journal of International Oncology, 2024, 51(4): 239-244.
[2]	Liu Xiaojie, Huang Junxing. Research progress of NADPH oxidase 2 in malignant tumors [J]. Journal of International Oncology, 2023, 50(10): 618-621.
[3]	Xiao Nan, Sun Pengfei. Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas [J]. Journal of International Oncology, 2022, 49(6): 357-361.
[4]	Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min. Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species [J]. Journal of International Oncology, 2022, 49(5): 257-262.
[5]	Zhang Yongli, Zhang Ruojia, Fan Huancai, Ge Luna, Wang Lin. TXNDC5-Prx2 axis regulates drug resistance of prostate cancer cells [J]. Journal of International Oncology, 2021, 48(8): 473-478.
[6]	Wang Mopei, Ma Liwen. Adjuvant chemotherapy for upper tract urothelial carcinoma [J]. Journal of International Oncology, 2020, 47(7): 436-439.
[7]	Xu Yiyue, Zhao Shaorong, Liu Jingjing, Zhang Jin. Mechanisms of ferroptosis and its significance in breast cancer therapy [J]. Journal of International Oncology, 2020, 47(6): 372-376.
[8]	Yang Yiting, Cheng Zhongping. The role of inflammatory cytokines in chemoresistance of epithelial ovarian cancer [J]. Journal of International Oncology, 2020, 47(4): 249-251.
[9]	Yi Lin, Qiu Shi. Anti-tumor effect and mechanisms of shikonin on gliomas [J]. Journal of International Oncology, 2019, 46(8): 489-491.
[10]	Xiong Bobo, Zhang Jinsong, Li Ning, Wang Haifeng, Zuo Yigang, Wang Jiansong. Molecular targeted therapy for advanced kidney cancer [J]. Journal of International Oncology, 2019, 46(12): 705-710.
[11]	Wu Lan, Li Wei, Zhang Dawei, Jiang Xuejun. Anti-tumor mechanism and application of tumor treatment of cold atmosphere plasma [J]. Journal of International Oncology, 2018, 45(11): 685-687.
[12]	DU Ji-Hui, ZHANG Hou-De, WEI Jing, WANG Lei, SUN Ting-Ji. Correlation of peroxisome pathway reactive oxygen species oxidative stress gene and its correlation with the antitumor sensitivity of artesunate against pancreatic cancer [J]. Journal of International Oncology, 2016, 43(7): 503-507.
[13]	Guan Xuwen, Huang Dingzhi. Roles of MTH1 gene in the occurrence and treatment of cancers [J]. Journal of International Oncology, 2016, 43(1): 26-28.
[14]	YAO Zhi-Feng, YAO Jian-Xin, LIU Yong-Biao. Antitumor effect of piplartine and its mechanism [J]. Journal of International Oncology, 2013, 40(4): 259-263.
[15]	ZHANG Hou-Li, CUI Shu-Xiang. Reactive oxygen species and tumor therapy [J]. Journal of International Oncology, 2012, 39(7): 504-507.